MedCity News December 29, 2025
A handful of states have issued guidance documents that illustrate how regulators are viewing the IV hydration and IV therapy businesses, which infusion providers should consider as part of their overall compliance monitoring efforts.
Pharmacy providers are increasingly moving into the infusion space – either standing up ambulatory infusion suites (“AIS”) or proving home infusion delivery models – despite unclear licensure requirements. While this space heats up given the significant market growth potential, providers need to monitor regulation developments as different states have begun issuing related guidance. And, as providers seek investment from private equity backers to facilitate their entry into the arena, a comprehensive review of federal and state laws, regulations, and guidance should remain a central focus of...







